Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis

Abstract

AAA-associated LOR frequently occurs in long-term treatment with ADA for JIA-associated uveitis. Concomitant immunosuppressive therapy significantly reduces the risk of LOR due to AAA.